Share this article
Share this article
LISBON, Portugal, Jan. 12, 2021 /PRNewswire/ Hovione, the leader in Pharmaceutical Spray Drying, today announced the launch of ASD-HIPROS, a proprietary screening service for spray dried dispersions. This platform is the most advanced and most accurate tool to identify optimal and commercially viable Amorphous Solid Dispersions formulation by Spray Drying (ASDs). During drug development, it is crucial to quickly find the optimal formulation assuring fast progress to clinical supplies and minimal formulation changes till commercialization.
ASD-HIPROS, the Hovione Intelligent PROprietary Screening methodology, is able to rapidly screen for the best combination of polymers, drug loads, surfactants and solvents by using an advanced computational tool followed by producing scale-independent representative samples of the most promising formulations, which are evaluated for performance and stability.
Dimensional Innovations Names Jeff Mikes New Corporate Practice Director
Mikes brings over 20 years of innovation and tech background to experience design firm
News provided by
Share this article
Share this article
KANSAS CITY, Mo., Jan. 12, 2021 /PRNewswire/ Dimensional Innovations (DI) is proud to announce it has named Jeff Mikes as Practice Director to spearhead growth with large Corporate clients. With over 20 years in the digital, technology and design industries, Mikes will partner with clients to drive experience innovation in workplaces and headquarters, sales centers, experiential marketing, retail, and branded environments. DI is an industry leader in experience design and build, so I m thrilled to be joining the team and expanding our footprint in corporate America, said Mikes. Developing a brand s story and igniting conversation through engaging experiences can help clients deepen relationships with new and existing customers, retain talented employees, and r
Natera to Present New Colorectal Cancer Data at the 2021 ASCO GI Symposium
Oral presentation showcases the largest early-stage CRC cohort to date, further validating the serial use of Signatera™ for early recurrence detection and MRD assessment
News provided by
Share this article
SAN CARLOS, Calif., Jan. 12, 2021 /PRNewswire/
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its personalized and tumor-informed molecular residual disease (MRD) test, Signatera, at the American Society of Clinical Oncology s 2021 Gastrointestinal Cancers Symposium (ASCO GI), taking place January 15-17, 2021.
Natera will have one oral and one poster presentation, each describing the clinical performance of Signatera in patients with colorectal cancer (CRC).
/PRNewswire/ The Sacramento Metropolitan Chamber of Commerce announced it will name Cate Dyer, CEO of StemExpress, the "Businesswoman of the Year" at their.
Medical Microinstruments Appoints Healthcare Industry Veteran Mark Toland as Chief Executive Officer
USA - English
News provided by
Share this article
Share this article
CALCI, Italy, Jan. 12, 2021 /PRNewswire/ Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today the hiring of Mark Toland as Chief Executive Officer. He brings more than 25 years of experience in the medical device industry and most recently served as President and CEO of Corindus, a vascular robotics company that Siemens Healthineers acquired for $1.1 billion in 2019. Following the CE mark of MMI s Symani Surgical System® in 2019 and successfully completing the first human use cases in 2020, Toland will drive the company s strategic direction from the developmental stage to broad commercialization.